Osteo Advance
Natural health product licensed in Canada
- Licence holder
- IDLife, LLC
- NPN or DIN-HM
- 80070326
- Status
- Active licence
- Licence date
- 14 June 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Diglycinate de zinc | 1.5 milligramme | 1,500 µg |
| Vitamine D Source : Cholécalciférol Potency : 40 UI | 10 microgrammes | Not calculated |
| Vitamin K2 Source : Vitamin K2 | 5 microgrammes | Not calculated |
| Cuivre Source : Diglycinate de cuivre (II) | 250 microgrammes | Not calculated |
| Vitamin K1 Source : Vitamine K1 | 45 microgrammes | Not calculated |
| Calcium Source : Carbonate de calcium | 300 milligramme | 300,000 µg |
| Calcium Source : Citrate malate de calcium | 300 milligramme | 300,000 µg |
| Magnésium Source : Oxyde de magnésium | 80.5 milligramme | 80,500 µg |
| Magnésium Source : Citrate de magnésium | 80.5 milligramme | 80,500 µg |
| Manganèse Source : Diglycinate de manganèse (II) | 0.25 milligramme | 250 µg |
| Equisetum arvense Source : Sommité | 2 milligramme | Not calculated |
| Boron Source : Acide borique | 0.7 milligramme | Not calculated |
Non-medicinal ingredients
Glycine, Microcrystalline cellulose, Stéarate de magnésium, Acide stéarique, silice, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth, the absorption and use of calcium and phosphorus, to maintain proper muscle function and to produce and repair connective tissue. Vitamin and mineral supplement for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80070326
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.